|
Deuterium-enriched vitamin A slows rate of age-related macular degeneration in a mouse model. |
 |
 |
|
Columbia University: When given to mice with the same genetic defect as humans with Stargardt’s disease, which usually experience early vision loss, the modified vitamin A resulted in fewer vitamin A dimers, better overall ocular health and improved vision. Importantly, they also observed that the modified vitamin A behaved exactly as normal vitamin A does in all other aspects, making it an attractive potential therapy for preventing blindness in humans.
|
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
